Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0100191136
Mon, 07.12.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Therapeutics and NeuroRx Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100(TM) for Critical COVID-19 with Respiratory Failure 07.12.2020 / 07:00 Relief Therapeutics and NeuroRx Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF [ … ]
Technical analysis
To the publication
Wed, 25.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study results Correction: NeuroRx and Relief announce initial successful results from expanded access use of RLF-100(TM) (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients 25.11.2020 / 18:27 Correction: NeuroRx an [ … ]
Technical analysis
To the publication
Tue, 24.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study results NeuroRx and Relief announce initial successful results from expanded access use of RLF-100(TM) (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients 24.11.2020 / 07:12 NeuroRx and Relief announce initia [ … ]
Technical analysis
To the publication
Mon, 23.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM Relief Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG 23.11.2020 / 07:00 Relief Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AGGeneva, Switzerland, November 23, 2020 - RELIEF THERAPEUTIC [ … ]
Technical analysis
To the publication
Wed, 18.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous Relief Selects CRO and CDMO for RLF-100TM in Europe 18.11.2020 / 07:00 Relief Selects CRO and CDMO for RLF-100TM in Europe European clinical assessment of RLF-100(TM) for the treatment of COVID-19 induced lung injury planned to begin in Q1 2021 Genev [ … ]
Technical analysis
To the publication
Fri, 13.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief, with Partner NeuroRx, Announces Enrollment of 150 Patients in Phase 2b/3 Trial of RLF-100(TM) for Critical COVID-19 with Respiratory Failure 13.11.2020 / 07:00 Relief, with Partner NeuroRx, Announces Enrollment of 150 Patients in Phase 2b/3 Trial of RLF [ … ]
Technical analysis
To the publication
Thu, 05.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study results Relief Therapeutics and NeuroRx announce continuation of RLF-100(TM) trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020 05.11.2020 / 07:00 Relief Therapeutics and NeuroRx announce continuation of RLF-10 [ … ]
Technical analysis
To the publication
Wed, 04.11.2020       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Personnel Relief Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Strengthen Management Team 04.11.2020 / 07:00 Relief Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Strengthen Management Team Geneva, Switzerland, November 04, 2020 - RELIEF THERAPEUT [ … ]
Technical analysis
To the publication
Tue, 13.10.2020       Relief Therapeutics Holdings AG
CH0100191136

EQS Group-News: Relief Therapeutics Holdings AG / Key word(s): Study results NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100(TM) (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19 13.10.2020 / 07:00 NeuroRx and Relief an [ … ]
Technical analysis
To the publication
Thu, 08.10.2020       Relief Therapeutics Holdings AG
CH0100191136

EQS Group-News: Relief Therapeutics Holdings AG / Key word(s): Personnel Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer 08.10.2020 / 07:00 Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and TreasurerGeneva, Switzerland, October 08 [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 06.10.2024, Calendar Week 40, 280th day of the year, 86 days remaining until EoY.